AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Director's Dealing 2014

Dec 9, 2014

Director's Dealing

Opens in your device viewer

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2014-12-08

Reporting Person: Pascale Adam (Chief Accounting Officer)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-08	Options to buy Common Stock	$1.9	J	7176	Acquired	2024-12-07	Common Stock (7176)	Direct

F1: 7,176 Options were issued on 12/8/14 to Adam Pascale to replace 7,176 options that expired on 12/7/14.